These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1379094

  • 21. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy.
    Odibo A.
    Br J Obstet Gynaecol; 1996 Nov; 103(11):1173-4. PubMed ID: 8917014
    [No Abstract] [Full Text] [Related]

  • 22. [Focus on preanalytics for Down's syndrome screening during first trimester of pregnancy].
    Gebeile R, Roger C, Doche C, Doche L.
    Ann Biol Clin (Paris); 2014 Nov; 72(2):207-12. PubMed ID: 24736141
    [Abstract] [Full Text] [Related]

  • 23. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 24. [First trimester ultrasound screening for nuchal translucency as marker of Down's syndrome].
    Herman A, Maymon R, Dreazen E, Bukovsky I, Weinraub Z.
    Harefuah; 1997 Jan 15; 132(2):94-100. PubMed ID: 9119309
    [No Abstract] [Full Text] [Related]

  • 25. Prenatal cytogenetic screening.
    Simpson JL.
    Ultrasound Obstet Gynecol; 1995 Jan 15; 5(1):3-5. PubMed ID: 7531607
    [No Abstract] [Full Text] [Related]

  • 26. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M, Nørgaard-Pedersen B.
    Clin Genet; 2005 Jul 15; 68(1):35-9. PubMed ID: 15952984
    [Abstract] [Full Text] [Related]

  • 27. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB.
    N Engl J Med; 1992 Aug 27; 327(9):588-93. PubMed ID: 1379344
    [Abstract] [Full Text] [Related]

  • 28. Introduction of first trimester combined test increases uptake of Down's syndrome screening.
    Tringham GM, Nawaz TS, Holding S, Mcfarlane J, Lindow SW.
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov 27; 159(1):95-8. PubMed ID: 21839574
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
    Go AT, Hupkes HW, Lomecky M, Twisk J, Blankenstein JM, van Vugt JM.
    Ned Tijdschr Geneeskd; 2005 Dec 10; 149(50):2795-9. PubMed ID: 16385832
    [Abstract] [Full Text] [Related]

  • 30. [Prenatal screening for Down's syndrome].
    Qin Q, Christiansen M, Norgaard-Pedersen B.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov 10; 32(11):694-7. PubMed ID: 9639772
    [No Abstract] [Full Text] [Related]

  • 31. Prenatal screening for Down's syndrome.
    BMJ; 1991 Jul 06; 303(6793):54-6. PubMed ID: 1830503
    [No Abstract] [Full Text] [Related]

  • 32. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K.
    Ann Clin Biochem; 2003 May 06; 40(Pt 3):219-31. PubMed ID: 12803832
    [Abstract] [Full Text] [Related]

  • 33. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN.
    Ultrasound Obstet Gynecol; 1997 Dec 06; 10(6):381-6. PubMed ID: 9476320
    [Abstract] [Full Text] [Related]

  • 34. Choosing the best prenatal screening protocol.
    Simpson JL.
    N Engl J Med; 2005 Nov 10; 353(19):2068-70. PubMed ID: 16282182
    [No Abstract] [Full Text] [Related]

  • 35. Prenatal screening for Down's syndrome.
    BMJ; 1991 Sep 21; 303(6804):715-6. PubMed ID: 1833015
    [No Abstract] [Full Text] [Related]

  • 36. Antenatal diagnosis of Down's syndrome.
    Gaudoin MR.
    BMJ; 1993 Mar 20; 306(6880):791-2. PubMed ID: 8363655
    [No Abstract] [Full Text] [Related]

  • 37. Prenatal screening for Down's syndrome.
    BMJ; 1991 Aug 24; 303(6800):468-9. PubMed ID: 1833008
    [No Abstract] [Full Text] [Related]

  • 38. Undetectable pregnancy-associated plasma protein-A in antenatal serum Down's syndrome screening: a case of assay interference.
    Williams C, Hambridge K, Petchey M, Martin JA, Spencer K.
    Ann Clin Biochem; 2015 Sep 24; 52(Pt 5):615-9. PubMed ID: 25995284
    [Abstract] [Full Text] [Related]

  • 39. Screening for Down's syndrome.
    McFadyen IR.
    BMJ; 1988 Nov 19; 297(6659):1335-6. PubMed ID: 2974310
    [No Abstract] [Full Text] [Related]

  • 40. Prenatal screening for Down's Syndrome.
    Round A, Hamilton W.
    BMJ; 1993 Nov 06; 307(6913):1211-2. PubMed ID: 8251854
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.